Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial
Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision version was updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the documentation.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a small site update. No study information or user-facing content appears to be altered.SummaryDifference0.1%

- Check30 days agoChange DetectedResults posting details were added to the record, indicating that results were posted on 2026-06-16 with associated outcome descriptions and a linked Study Protocol and Statistical Analysis Plan PDF. The reported number of patients with dose modification due to toxicity was updated to 73 (from 75).SummaryDifference2%

- Check37 days agoChange DetectedThe page now signals that recruitment is closed and provides enhanced guidance sections to help readers understand the study details and joining process.SummaryDifference0.5%

- Check44 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a new version of the page has been published. This typically reflects minor edits or metadata updates to the study record.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision/version shown on the page was updated from v3.5.3 to v3.5.4, indicating a new release of the document or tool. This change updates the metadata without altering visible content or functionality.SummaryDifference0.1%

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.